Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – the clinical expert behind the software – discusses why optometrists should embrace the technology and its potential in other health fields.
National Optical Care has arrived by acquiring 14 practices and launching a new buying group and managed services division. CEO MR JASON GOWIE explains the company’s ambitions for the eyecare sector and how it plans to make a positive impact. Read more
Whether it’s digital marketing, succession planning or practice acquisition, an increasing number of independents are turning to Eyecare Plus to ensure the viability of their business in an ever-changing optometric landscape.
A new era in ophthalmic surgery has dawned with the emergence of 3D visualisation systems. Surgeons discuss how Alcon’s latest advance in this field is offering new levels of comfort, efficiency and teaching advantages in Australian operating theatres.
As part of Macula Month this May, Insight examines drug development programs that could significantly alter the late-stage AMD therapy landscape. Leading experts also discuss why optometrists are such an important link in the success of both patient outcomes and clinical trials.
Optos’s ultra-widefield imaging systems are renowned for some of the most superior views of the retina, but the company recently went a step further to incorporate swept source OCT. DR DAVID SIA from Pennington Eye Clinic – Australia’s first practice to have Silverstone installed – discusses why it’s so beneficial for vitreoretinal specialists, ocular oncologists and beyond.
Bausch + Lomb’s latest version of the enVista monofocal recently became available to Australian and New Zealand surgeons along with a new pre-loaded delivery system. Early adopters discuss making it a go-to IOL and how it’s offering increased depth-of-field in many patients.
Buy now, pay later is the latest trend in flexible payment services. With financial providers racing to grab their share, what impact is this having for the eyecare sector in terms of new customers, product sales and cash flow? RHIANNON BOWMAN reports.
Two years since the KeepSight launch, Insight asks what measurable difference this once-in-a-generation program is making to those living with the diabetes.
Trends already shaping modern optometry were set on an even steeper trajectory with the advent of COVID-19. MS HILKE FITZSIMONS explains why Zeiss Vision Care’s future-focused products are well-positioned to support optometry during its next evolution.